全文获取类型
收费全文 | 163060篇 |
免费 | 8771篇 |
国内免费 | 151篇 |
专业分类
耳鼻咽喉 | 2602篇 |
儿科学 | 5729篇 |
妇产科学 | 3917篇 |
基础医学 | 24248篇 |
口腔科学 | 5825篇 |
临床医学 | 13867篇 |
内科学 | 29460篇 |
皮肤病学 | 4309篇 |
神经病学 | 16649篇 |
特种医学 | 6713篇 |
外科学 | 24940篇 |
综合类 | 761篇 |
一般理论 | 48篇 |
预防医学 | 9344篇 |
眼科学 | 3484篇 |
药学 | 11184篇 |
中国医学 | 242篇 |
肿瘤学 | 8660篇 |
出版年
2023年 | 918篇 |
2022年 | 708篇 |
2021年 | 1672篇 |
2020年 | 1538篇 |
2019年 | 1930篇 |
2018年 | 3380篇 |
2017年 | 2880篇 |
2016年 | 3688篇 |
2015年 | 3298篇 |
2014年 | 3762篇 |
2013年 | 6383篇 |
2012年 | 8067篇 |
2011年 | 8959篇 |
2010年 | 5166篇 |
2009年 | 3914篇 |
2008年 | 8881篇 |
2007年 | 9369篇 |
2006年 | 9085篇 |
2005年 | 9033篇 |
2004年 | 8430篇 |
2003年 | 8442篇 |
2002年 | 8249篇 |
2001年 | 5799篇 |
2000年 | 7025篇 |
1999年 | 4321篇 |
1998年 | 1869篇 |
1997年 | 1571篇 |
1996年 | 1252篇 |
1995年 | 1079篇 |
1994年 | 1047篇 |
1993年 | 940篇 |
1992年 | 1444篇 |
1991年 | 1312篇 |
1990年 | 1331篇 |
1989年 | 1338篇 |
1988年 | 1179篇 |
1987年 | 1247篇 |
1986年 | 1087篇 |
1985年 | 1208篇 |
1984年 | 1096篇 |
1983年 | 917篇 |
1982年 | 832篇 |
1981年 | 762篇 |
1980年 | 686篇 |
1979年 | 830篇 |
1978年 | 684篇 |
1977年 | 665篇 |
1976年 | 593篇 |
1975年 | 618篇 |
1974年 | 627篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
51.
Béla Nagy Zsolt Bene Zsolt Fejes Sonya L. Heltshe David Reid Nicola J. Ronan Yvonne McCarthy Daniel Smith Attila Nagy Elizabeth Joseloff György Balla János Kappelmayer Milan Macek Scott C. Bell Barry J. Plant Margarida D. Amaral István Balogh 《Journal of cystic fibrosis》2019,18(2):271-277
Background
We have recently shown that human epididymis protein 4 (HE4) levels correlate with the severity of cystic fibrosis (CF) lung disease. However, there are no data on how HE4 levels alter in patients receiving CFTR modulating therapy.Methods
In this retrospective clinical study, 3 independent CF patient cohorts (US-American: 29, Australian: 12 and Irish: 19 cases) were enrolled carrying at least one Class III CFTR CF-causing mutation (p.Gly551Asp) and being treated with CFTR potentiator ivacaftor. Plasma HE4 was measured by immunoassay before treatment (baseline) and 1–6?months after commencement of ivacaftor, and were correlated with FEV1 (% predicted), sweat chloride, C-reactive protein (CRP) and body mass index (BMI).Results
After 1?month of therapy, HE4 levels were significantly lower than at baseline and remained decreased up to 6?months. A significant inverse correlation between absolute and delta values of HE4 and FEV1 (r?=??0.5376; P?<?.001 and r?=??0.3285; P?<?.001), was retrospectively observed in pooled groups, including an independent association of HE4 with FEV1 by multiple regression analysis (β?=??0.57, P?=?.019). Substantial area under the receiver operating characteristic curve (ROC-AUC) value was determined for HE4 when 7% mean change of FEV1 (0.722 [95% CI 0.581–0.863]; P?=?.029) were used as classifier, especially in the first 2?months of treatment (0.806 [95% CI 0.665–0.947]; P?<?.001).Conclusions
This study shows that plasma HE4 levels inversely correlate with lung function improvement in CF patients receiving ivacaftor. Overall, this potential biomarker may be of value for routine clinical and laboratory follow-up of CFTR modulating therapy. 相似文献52.
A method is presented for 3D MRI in an extended field of view (FOV) based on continuous motion of the patient table and an efficient acquisition scheme. A gradient-echo MR pulse sequence is applied with lateral (left-right (L/R)) frequency-encoding direction and slab selection along the direction of motion. Compensation for the table motion is achieved by a combination of slab tracking and data alignment in hybrid space. The method allows fast k-space coverage to be achieved, especially when a short sampling FOV is chosen along the direction of table motion, as is desirable for good image quality. The method can be incorporated into different acquisitions schemes, including segmented k-space scanning, which allows for contrast variation with the use of magnetization preparation. Head-to-toe images of volunteers were obtained with good quality using 3D spoiled gradient-echo sequences. As an example of magnetization-prepared imaging, fat/water separated images were acquired using chemical shift selective (CHESS) presaturation pulses. 相似文献
53.
Dr. H. Ptok R. Steinert F. Meyer K.-P. Kröll C. Scheele F. Köckerling I. Gastinger H. Lippert 《Der Chirurg》2006,77(8):709-717
BACKGROUND: The laparoscopic resection of rectal cancer shows morbidity and oncological safety comparable to the open approach, but morbidity increases after conversion to open resection. No oncological long-term results are available for the latter patients. METHODS: From 01/01/2000-31/12/2002, patients with curatively resected rectal cancer enrolled in a observational study were evaluated for morbidity, mortality, tumor- and local recurrence rate, paying attention to patients with conversion from laparoscopic to open resection. RESULTS: 237 (3.3%) of 7,189 patients underwent laparoscopic resection (ITT). These patients showed significantly more T1/2 tumors (P<0.001) in earlier UICC stages (P<0.001) than open resected patients. 35 (14.8%) of 237 laparoscopic procedures were converted. Compared with patients receiving complete laparoscopic or open resection, these patients showed significantly higher frequencies of intraoperative (P<0.001) and general postoperative complications (P=0.003) as well as the highest overall morbidity (P=0.031). After a median follow-up of 30.1 months, the highest 5-year local recurrence rate was found in the converted group (16.0%). The laparoscopically resected patients showed a local recurrence rate of 3.3%, patients with open resection of 12.4% (P=0.082). The disease-free survival rate did not differ between the groups (P=0.585). CONCLUSION: Laparoscopic resection of rectal cancer provides oncological results similar to open resection. After conversion, the short and oncological long-term outcomes were worse. Considering a conversion rate of 15%, only a strict indication for the laparoscopic approach can be allowed, and laparoscopic resection should be performed at centers. 相似文献
54.
Mariagrazia Marucci Gert Ragnarsson Anders Axelsson 《Journal of controlled release》2006,114(3):369-380
In this work, Electronic Speckle Pattern Interferometry (ESPI) is presented as a non-invasive tool to study drug transport in controlled release systems. ESPI is shown to be a feasible tool to measure drug film permeability via comparison with an ordinary diaphragm cell. A specially designed cuvette was used in the release study: the polymeric film separated the donor and the receiving chambers of the cuvette to create a diffusion cell with no mixing in the two chambers. Thus, the cuvette mimicked a coated system immersed in a stagnant bulk liquid. Concentration profile data were obtained for the two compartments. Using these data, it was possible to visually discriminate between a film subject only to diffusion and a film subject to diffusion as well as osmotic effects. Moreover, using the concentration profile data collected at different time intervals, it was possible to follow the film properties in terms of drug permeability, thus studying how drug permeability depended on drug concentration. Compared to other measuring techniques, ESPI offers the advantages that no invasive measurements are needed, and that no sampling and calibration are required. Furthermore, the permeability can be measured with no influence of mass transfer in the boundary layers. 相似文献
55.
56.
57.
58.
59.
60.